mdlinx mdlinx
Latest (26) Full Text Articles (287) Focus on Spondylarthropathies Article Summary

The Impact of TNF-inhibitors on radiographic progression in Ankylosing Spondylitis
Arthritis & Rheumatism,  Clinical Article

Haroon N et al. – The authors studied the effect of Tumor Necrosis Factor–Alpha (TNF)–inhibitors on progressive spine damage in Ankylosing Spondylitis (AS) patients. TNF–inhibitors appear to reduce radiographic progression in AS, especially with early initiation and longer duration of follow up.

Methods

  • All AS patients (satisfying the modified New York criteria) prospectively followed and with at least two sets of spinal radiographs at a minimum gap of 1.5 years were included (n=334).
  • Patients received clinical standard of care, which included non-steroidal anti-inflammatory drugs and TNF-inhibitors.
  • Radiographic severity was assessed by the modified Stokes Ankylosing Spondylitis Spine Score (mSASSS).
  • Patients with a rate of progression more than 1 mSASSS unit/year were considered progressors.
  • Univariable and multivariable regression analyses were done.
  • Propensity score matching (PSM) and sensitivity analysis were performed.
  • A zero-inflated negative binomial (ZINB) model was used to analyze the effect of TNF-inhibitor on change in mSASSS with varying follow-up periods.
  • Potential confounders like Bath AS Disease Activity Index (BASDAI), ESR, CRP, HLA-B27, gender, age of onset, smoking and baseline damage were included in the model.

Results

  • TNF-inhibitor treatment was associated with a 50% reduction in the odds of progression (OR: 0.52; CI: 0.30-0.88; p=0.02).
  • Patients with a delay in starting therapy of more than 10 years were more likely to progress compared to those who started earlier (OR=2.4; 95% CI: 1.09-5.3; p=0.03).
  • In the ZINB model TNF-inhibitor use significantly reduced progression when the gap between x-rays was more than 3.9 years.
  • The protective effect of TNF-inhibitors was stronger after propensity score matching.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

Last month's top read Top Articles of 2013

1 Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study Rheumatology, February 11, 2014    Clinical Article

2 New discovery on Giant Cell Arteritis sheds light on cause Full Text ScienceDaily, January 21, 2014    Free full text

3 Ten common mistakes in the management of lupus nephritis American Journal of Kidney Diseases, January 3, 2014    Clinical Article

4 Autoantibodies and SLE- The threshold for disease Nature Reviews Rheumatology , December 5, 2013    Review Article

5 Vitamin D and cutaneous lupus erythematosus: Effect of vitamin D replacement on disease severity Lupus, February 12, 2014    Clinical Article

6 Effect of hydroxychloroquine on the lipid profile of patients with Sjogren's syndrome The Journal of Rheumatology, March 17, 2014    Clinical Article

7 3 Things Doctors Should Know About Obamacare U.S. News & World Report - Health, December 18, 2013

8 Interstitial lung disease in patients with rheumatoid arthritis: Spontaneous and drug induced Drugs, March 3, 2014    Clinical Article

9 New compound dramatically reduces joint inflammation Full Text ScienceDaily, December 12, 2013    Free full text

10 Treatment of asymptomatic hyperuricemia and prevention of vascular disease: A decision analytic approach The Journal of Rheumatology, March 4, 2014    Clinical Article

11 Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis Annals of Rheumatic Diseases, January 6, 2014    Evidence Based Medicine    Review Article
Exclusive Author Commentary

12 Weather may truly affect arthritis pain Full Text Reuters Health News, February 13, 2014    Free full text

13 An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia International Journal of Rheumatic Diseases, February 10, 2014    Clinical Article

14 Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjogren's syndrome Rheumatology, March 11, 2014    Clinical Article

15 Biomarkers in vasculitis Current Opinion in Rheumatology, December 4, 2013    Clinical Article

16 Late-onset neutropenia in patients with rheumatoid arthritis after treatment with rituximab The Journal of Rheumatology, March 17, 2014    Clinical Article

17 Up-titration of allopurinol in patients with gout Seminars in Arthritis and Rheumatism, February 3, 2014    Review Article

18 Cigarette smoking and risk of rheumatoid arthritis: A dose-response meta-analysis Arthritis Research & Therapy, March 7, 2014    Clinical Article

19 Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study Clinical Rheumatology, February 17, 2014    Clinical Article

20 Cancer mutation likely trigger of scleroderma Full Text ScienceDaily, December 9, 2013    Free full text

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close